semaglutide
In 2023, trials showed a 14% reduction in major heart events among GLP-1 users, proving the same medication that helps you shed pounds can also lower heart-failure risk, regardless of weight loss. Studies now link these drugs to improved cardiac outcomes beyond the scale. Medical Disclaimer: This article is for
semaglutide
A single 50-minute dose of semaglutide or tirzepatide can cut the risk of heart attack or stroke by over 30%. Both drugs lower cardiovascular events, yet tirzepatide demonstrates a modest edge in major adverse cardiovascular events, making it the slightly stronger heart-saver. Medical Disclaimer: This article is for informational purposes
semaglutide
Semaglutide and tirzepatide often look similar on a price tag, but when gastrointestinal side effects are added, the total out-of-pocket expense can exceed $7,000 a year for many patients. In 2023, claims data showed an extra $4,500 per year in GI-related services for people using GLP-1 weight-loss drugs,
GLP-1 / weight-loss drugs
Seniors can reduce out-of-pocket GLP-1 expenses by $200-$300 a year by leveraging tiered Medicare formularies, pharmacy rebates, and negotiated copay strategies. In my practice I see patients surprised when a month of semaglutide costs as much as a utility bill, yet most are unaware that the system offers hidden